Neoadjuvant chemoradiotherapy for thoracic esophageal squamous cell carcinoma: does everyone need it?

Objective. In accordance with clinical guidelines, neoadjuvant chemoradiotherapy (nCRT) is recommended as a beneficial option for treatment of thoracic esophageal squamous cell carcinoma (TESCC). However, some studies did not demonstrate potential benefits of nCRT. In this paper we compared treatmen...

Celý popis

Podrobná bibliografie

Hlavní autoři:	D. A. Chichevatov, E. N. Sinev, A. E. Glukhov, O. M. Seliverstova
Médium:	Artigo
Jazyk:	Russo
Vydáno:	Russian Academy of Sciences, Tomsk National Research Medical Center 2024-05-01
Edice:	Сибирский онкологический журнал
Témata:	squamous cell esophageal carcinoma chemoradiation therapy surgery
On-line přístup:	https://www.siboncoj.ru/jour/article/view/3034
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!